DNAPrint Genomics, Inc. (DNAG)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 20, 2026, 4:00 PM EST
DNAPrint Genomics Market Cap
DNAPrint Genomics has a market cap or net worth of $1.3 thousand as of January 23, 2026. Its market cap has decreased by -99.80% in one year.
Market Cap
1.30K
Enterprise Value
n/a
Revenue
1.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 11, 1996, DNAPrint Genomics's market cap has decreased from 12.11M to 1.30K, a decrease of -99.99%. That is a compound annual growth rate of -26.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.30K | - |
| Dec 13, 2024 | 1.30K | - |
| Dec 28, 2023 | 1.30K | - |
| Dec 30, 2022 | 1.30K | - |
| Dec 31, 2021 | 1.30K | -99.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoveren Scientific | 3.20K |
| OncoVista Innovative Therapies | 2.36K |
| ZIM Corporation | 1.63K |
| 9 Meters Biopharma | 1.45K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| eFFECTOR Therapeutics | 941.00 |
| Pathfinder Cell Therapy | 667.00 |